Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ragweed Pollen Challenge in ACC
NCT03496103Phase 1Completed
- Sponsor
- The University of Texas Medical Branch at Galveston
- Start
- Feb 2016
- Primary completion
- Mar 2016
01
Overview
Phase 1, open-label trial (2 arms), sponsored by The University of Texas Medical Branch at Galveston. Primary endpoint: Effect of ragweed pollen exposure at 3 hours. Started Feb 2016; status: completed.
Beyond the preview
Go deeper on NCT03496103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03496103.